Eventos

SARS-CoV-2 infection among healthcare professionals: demographic characteristics and serological and immune responses related to progression's phenotype

Concepció Violán Fors

Family physician, IP GrenSSaP group IDIAPJGol. Unitat de suport a la Rercerca . Metropolitana Nord. ICS. Associated researcher IGTP

Date and time: | 09.00-10.00

Venue: Online

Abstract

One of the key questions is if people who have been infected with SARS-CoV-2, whether symptomatic or asymptomatic, knowingly or unknowingly, develop permanent immunity to the virus. Aim: To describe a cohort of health professionals exposed to SARS-CoV-2 by measuring immunological parameters  that allow to distinguish symptomatic from asymptomatic carriers. Design: prospective study with four cohorts of health workers (Symptomatic  at the moment of the study); Healthy carriers; Non-infected symptomatic and asymptomatic professionals; Symptomatic and asymptomatic professionals with low level of exposure to SARS-Cov-2). Endpoint:           To characterise the population by means of algorithm to identify the carrier status and the immune response from the results obtained in the initial RT-PCR and the humoral and cellular response associated with the progression phenotype. The study will be carried out in collaboration with the Foundation University Institute for Primary Health Care Research Jordi Gol i Gurina  , Germans Trias i Pujol Research Institute IrsiCaixa and Metropolitana Nord Health Primary Care , Hospital Germans Trias i Pujol.

Speaker

  • Concepció Violán Fors, Family physician, IP GrenSSaP group  IDIAPJGol. Unitat de suport a la Rercerca . Metropolitana Nord. ICS. Associated researcher IGTP

Other researchers on the team

  • Pere Toran Monserrat, Family physician, Head of  Unitat de suport a la Rercerca . Metropolitana Nord. ICS. Associated researcher IGTP
  • Julia Garcia Prado, Biochemistry, IP Viral Immune Evasion and Vaccines (VIRIEVAC).  Scientific Director IGTP
  • Eva Martinez Caceres, Head Immunology Division Germans Trias i Pujol University Hospital. IP Immunopathology research group IGTP

Connect to this seminar here

or copy this link into your browser